Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study.
Juan Fita MJ, Anido Herranz U, Mendez-Vidal MJ, Gironés-Sarrió R, Muñoz-Langa J, Sepúlveda-Sánchez J, Mellado B, Alvarez-Fernandez C, Heras López L, López-Guerrero JA, García-Casado Z, Calatrava A, Ángel Climent M.
Juan Fita MJ, et al.
Cancers (Basel). 2023 Oct 31;15(21):5223. doi: 10.3390/cancers15215223.
Cancers (Basel). 2023.
PMID: 37958398
Free PMC article.
The SOGUG-IMANOL trial was a phase 2, uncontrolled, Spanish multicenter study to assess the effect of maintenance treatment with olaparib on radiographic progression-free survival (PFS) in patients with metastatic castration-resistant prostate cancer (mCRPC) who achieved p …
The SOGUG-IMANOL trial was a phase 2, uncontrolled, Spanish multicenter study to assess the effect of maintenance treatment with olap …